Recent Finacing
Recent Raise
Passkey Therapeutics develops Synergistic Multifunctional Therapeutics (SMThs) using its Locksmith computational–experimental platform to identify disease-relevant protein "Multilogs" from human genetic datasets and engineer small-molecule or biologic therapies.
